Bank of New York Mellon’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.01K Buy
10,080
+1
+0% +$1 ﹤0.01% 4283
2026
Q1
$4.61K Hold
10,079
﹤0.01% 4193
2025
Q4
$22.2K Buy
+10,079
New +$16.2K ﹤0.01% 4163
2025
Q2
Sell
-64,020
Closed -$76.2K 4288
2025
Q1
$76.2K Buy
64,020
+22,572
+54% +$36K ﹤0.01% 4029
2024
Q4
$85.4K Buy
41,448
+8,886
+27% +$20.7K ﹤0.01% 4039
2024
Q3
$82.4K Buy
+32,562
New +$106K ﹤0.01% 4024

Other funds holding GUTS

Bank of New York Mellon's GUTS Position: Q2 2026 in Review

Bank of New York Mellon increased its Fractyl Health (GUTS) stake by 0.01% in Q2 2026, buying an estimated $1 and bringing the position to 10,080 shares worth $8.01K. The position accounts for ﹤0.01% of the portfolio, ranked #4283.

Bank of New York Mellon first reported a position in GUTS in Q3 2024 and has held it in 6 quarters since. The position peaked at $85.4K in Q4 2024. 29 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Bank of New York Mellon held 10,080 shares of Fractyl Health worth $8.01K as of Q2 2026.
  • Bank of New York Mellon bought 1 Fractyl Health share in Q2 2026, an estimated $1.
  • Fractyl Health made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4283 holding.
  • Bank of New York Mellon first reported a position in Fractyl Health in Q3 2024 and has held it in 6 quarters since.
  • Bank of New York Mellon's Fractyl Health position peaked at $85.4K in Q4 2024.
  • 29 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.